Overview
Equip your research workflow with Tirzepatide from your research catalog — a high-purity, synthetic peptide studied extensively across biochemical and metabolic research pipelines. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, engineered with a C20 fatty diacid moiety that enables robust plasma protein binding and an extended half-life for experimental assays.
Each Tirzepatide vial is sealed under nitrogen for long-term stability and individually batch-tested for identity, purity, and consistency via independent HPLC-MS verification. Supplied as a lyophilised powder, it is designed for precise, controlled laboratory work and metabolic signaling studies.
